Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

P-21 cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established P-21 cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • P-21 combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established P-21 cycle length?
No. We found no human studies that report a treatment duration for P-21.
What is the longest human study of P-21?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
P-21 dosing reference Full research page

References

  1. Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice FEBS Letters. 2010
  2. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound Neurobiology of Aging. 2014
  3. Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound Journal of Alzheimer's Disease. 2015
  4. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome Scientific Reports. 2017
  5. Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice Alzheimer's Research & Therapy. 2020
  6. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound Biomolecules. 2022
  7. Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder Journal of Neurodevelopmental Disorders. 2024
  8. Corrigendum to: Diffusion MRI measures detect brain microstructure changes due to early treatment with neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease Magnetic Resonance Imaging. 2026
  9. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026) FDA. 2026
  10. ClinicalTrials.gov search for interventional studies of P021 (no records identified) ClinicalTrials.gov. 2026
  11. World Anti-Doping Code International Standard Prohibited List 2026 WADA. 2026